Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment

Eur J Neurol. 2010 Jan;17(1):e5. doi: 10.1111/j.1468-1331.2009.02839.x. Epub 2009 Oct 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anticonvulsants / therapeutic use
  • Autoantibodies / analysis
  • Autoantibodies / blood*
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / immunology*
  • Autoimmune Diseases / physiopathology
  • Azathioprine / therapeutic use
  • Biomarkers / analysis
  • Biomarkers / blood
  • Brain / metabolism
  • Brain / physiopathology
  • Cerebellar Ataxia / drug therapy
  • Cerebellar Ataxia / immunology*
  • Cerebellar Ataxia / physiopathology
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / immunology
  • Epilepsy, Generalized / drug therapy
  • Epilepsy, Generalized / immunology*
  • Epilepsy, Generalized / physiopathology
  • Female
  • Glutamate Decarboxylase / immunology*
  • Hashimoto Disease / complications
  • Hashimoto Disease / immunology
  • Humans
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / therapeutic use
  • Nystagmus, Pathologic / complications
  • Nystagmus, Pathologic / immunology
  • Prednisone / therapeutic use
  • Treatment Outcome
  • Vitamin B 12 Deficiency / complications
  • Vitamin B 12 Deficiency / immunology
  • gamma-Aminobutyric Acid / biosynthesis
  • gamma-Aminobutyric Acid / deficiency

Substances

  • Anticonvulsants
  • Autoantibodies
  • Biomarkers
  • Immunosuppressive Agents
  • gamma-Aminobutyric Acid
  • Glutamate Decarboxylase
  • Azathioprine
  • Prednisone